Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123367313 | 12336731 | 3 | F | 20160711 | 20160505 | 20160721 | EXP | US-ACORDA-ACO_123523_2016 | ACORDA | 0.00 | F | Y | 0.00000 | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123367313 | 12336731 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | U | 0000078764 | 22250 | 10 | MG | TABLET | BID | ||||
| 123367313 | 12336731 | 2 | C | Amantadine | AMANTADINE | 1 | U | 0 | |||||||||||
| 123367313 | 12336731 | 3 | C | Atorvastatin | ATORVASTATIN | 1 | U | 0 | |||||||||||
| 123367313 | 12336731 | 4 | C | AUBAGIO | TERIFLUNOMIDE | 1 | U | 0 | |||||||||||
| 123367313 | 12336731 | 5 | C | BACLOFEN. | BACLOFEN | 1 | U | 0 | |||||||||||
| 123367313 | 12336731 | 6 | C | BUPROPION. | BUPROPION | 1 | U | 0 | |||||||||||
| 123367313 | 12336731 | 7 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | U | 0 | |||||||||||
| 123367313 | 12336731 | 8 | C | LEVEMIR | INSULIN DETEMIR | 1 | U | 0 | |||||||||||
| 123367313 | 12336731 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | U | 0 | |||||||||||
| 123367313 | 12336731 | 10 | C | Oxybutynin | OXYBUTYNIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123367313 | 12336731 | 1 | Multiple sclerosis |
| 123367313 | 12336731 | 2 | Product used for unknown indication |
| 123367313 | 12336731 | 3 | Product used for unknown indication |
| 123367313 | 12336731 | 4 | Product used for unknown indication |
| 123367313 | 12336731 | 5 | Product used for unknown indication |
| 123367313 | 12336731 | 6 | Product used for unknown indication |
| 123367313 | 12336731 | 7 | Product used for unknown indication |
| 123367313 | 12336731 | 8 | Product used for unknown indication |
| 123367313 | 12336731 | 9 | Product used for unknown indication |
| 123367313 | 12336731 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123367313 | 12336731 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123367313 | 12336731 | 1 | 20130610 | 201604 | 0 |